Recommended NZ | Guide to Money | Gimme: Competitions - Giveaways

'PHARMAC ' | Search

Narrow by ...

Content type:

News (1101)


Politics (372)
Business (61)
National (111)
Sport (1)
Health (555)
Technology (1)


Fuseworks Media (1095)
Voxy Newswire (6)

Use 'Subscribe to an RSS feed of this search' to follow your favorite topics and authors

I'm looking for ...


Displaying 41 - 50 of 1101 results

Subscribe to an RSS feed of this search RSS icon

Pharmac proposes widened access to the flu vaccine for Maori and Pacific

Tuesday, 8 March, 2022 - 11:12

Pharmac is consulting on a proposal to widen access to the funded influenza vaccine to include Maori and Pacific peoples aged between 55 and 64 years of age for the 2022 influenza season.

Read the consultation on widening access

Flu vaccine price increase - Pharmac

Tuesday, 1 March, 2022 - 09:42

Pharmac has confirmed that the purchase price of the annual influenza vaccine will increase by $2 a dose, the first increase since 2008.

Pharmac ensures earlier access to key COVID-19 treatment - Pharmac

Monday, 28 February, 2022 - 14:18

The access criteria for remdesivir is being temporarily widened to allow hospitals to treat those with mild to moderate symptoms of COVID-19, who are at high risk of severe disease, as of today.

Pharmac proposing to widen access to funded medicines

Monday, 14 February, 2022 - 10:03

Pharmac has issued a consultation today on proposals to widen access to two medicines, rituximab and zoledronic acid, estimated to benefit 1,750 New Zealanders a year.

Free flu vaccines for more New Zealanders - Andrew Little

Tuesday, 8 February, 2022 - 16:22

The Government will fund a quarter of a million more free flu vaccines for this year’s winter campaign to protect our most vulnerable communities and the health system, Health Minister Andrew Little says.

Why summer can lead to an increased risk of gout - ProCare

Friday, 4 February, 2022 - 10:13

It wouldn’t be a summer in Aotearoa if we didn’t have barbeques, kai moana and the odd drink or two. However, this tasty combination can lead to an increased risk of gout warns ProCare, a leading healthcare provider.

Pharmac confirms access criteria for COVID treatments

Wednesday, 26 January, 2022 - 15:05

Pharmac has today confirmed the access criteria for two COVID-19 treatments - baricitinib and casirivimab with imdevimab (branded as Ronapreve). Both will be available for use in DHB hospitals from 1 February 2022.

NZ must move fast on next generation Covid-19 treatments - Chris Bishop

Tuesday, 25 January, 2022 - 14:46

The Government must move as fast as possible to approve and order supply of promising new Covid-19 treatments, National’s Covid-19 Response spokesperson Chris Bishop says.

Pharmac seeks views on patient access criteria for COVID-19 treatments

Wednesday, 22 December, 2021 - 14:14

Pharmac is releasing the October meeting records of their COVID-19 clinical expert advisory group and seeking feedback on the patient access criteria for two funded COVID-19 treatments - baricitinib and casirivimab and imdevimab (branded as Ronapreve).

Trans-Tasman Medicines Report: 'NZ appalling inequity gap exposed'

Monday, 20 December, 2021 - 12:01

A new report, Access to Medicines 3 (AtoM 3) generated by IQVIA, the world's largest healthcare data science company, showed that New Zealand is consistently publicly funding fewer cost-effective modern medicines than Australia and making funding decisions at a slower pace.